HIV Primary Infection: Clinical Trials

4 trials for HIV Primary Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 terminated. 3 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Terminated 1, Unknown 1
Phase 21Unknown 1

Follow HIV Primary Infection: new trials by email Literature Review of HIV Primary Infection trials Research Report on HIV Primary Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diagnostic Performance of a Novel Lipoarabinomannan.
FUJILAM KIT - HIV Primary Infection
Not applicableUnknownMédecins Sans Frontières, Kenya5502021-09-012021-09-08
A Multicomponent Intervention to Address Gender-based Violence in HIV
Kicking it with the Gurlz - Acceptability of Health Care, HIV Primary Infection
Not applicableCompletedUniversity of Michigan182021-07-012025-03-25
Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection
50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide - HIV Primary Infection
Phase 2UnknownAnna Cruceta662020-12-042021-07-19
A Couples-based Intervention for Transgender Women and Their Partners
CHIP, Control - HIV Infections, HIV Primary Infection
Not applicableTerminatedUniversity of Michigan1042019-11-012025-08-06

Narrower conditions

Acquired Immunodeficiency Syndrome (1)  ·  HIV Infections (1)  ·  Patient Acceptance of Health Care (1)

Broader conditions

Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Genital Diseases (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Lentivirus Infections (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)  ·  Sexually Transmitted Diseases (2)  ·  Sexually Transmitted Diseases, Viral (2)  ·  Urogenital Diseases (2)  ·  Virus Diseases (2)  ·  Behavior (1)  ·  HIV Infections (1)

Interventions

bictegravir (1)  ·  bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)

Sponsors

University of Michigan (2)  ·  Anna Cruceta (1)  ·  Médecins Sans Frontières, Kenya (1)

Countries

United States (2)  ·  Spain (1)

Top investigators

Ellen Stein (1)  ·  Kristi Gamarel, PhD (1)

Results publications

PMID 30003506, PMID 32415617, PMID 33060086

NIH funding

R01MH115765 (1), R21MH123218 (1)